Top compounds associated with response to SLC25A16


Feature Type Standardized
Nominal ANOVA
mRNA NPK76-II-72-1 GDSC1000 pan-cancer AAC -0.12 4e-05
mRNA Genentech Cpd 10 GDSC1000 pan-cancer AAC -0.13 4e-05
mRNA Topotecan CTRPv2 pan-cancer AAC -0.13 4e-05
mRNA doxorubicin:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 4e-05
mRNA SN-38 GDSC1000 pan-cancer AAC -0.13 8e-05
mRNA ceranib-2 CTRPv2 pan-cancer AAC -0.13 9e-05
mRNA docetaxel:tanespimycin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA YK 4-279 CTRPv2 pan-cancer AAC -0.12 0.0001
mRNA lapatinib CTRPv2 pan-cancer AAC 0.14 0.0001
mRNA GW843682X CTRPv2 pan-cancer AAC -0.13 0.0002
Download CSV